BNTX BioNTech SE
BioNTech SE (BNTX) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $4.6M.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Sahin Ugur | Chief Executive Officer | Sell | 41,000 | $99.45 | $4.1M | 602,209 −6.4% of holding | |
| Sahin Ugur | Chief Executive Officer | Sell | 45,000 | $96.93 | $4.4M | 643,209 −6.5% of holding | |
| Sahin Ugur | Chief Executive Officer | Sell | 20,500 | $96.31 | $2.0M | 688,209 −2.9% of holding | |
| Sahin Ugur | Chief Executive Officer | Sell | 36,000 | $97.78 | $3.5M | 708,709 −4.8% of holding | |
| Sahin Ugur | Chief Executive Officer | Sell | 37,000 | $99.20 | $3.7M | 744,709 −4.7% of holding | |
| Sahin Ugur | Chief Executive Officer | Sell | 31,500 | $103.52 | $3.3M | 781,709 −3.9% of holding | |
| Sahin Ugur | Chief Executive Officer | Sell | 45,000 | $102.85 | $4.6M | 813,209 −5.2% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.